Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier

Alexandre Hinzpeter, Abdel Aissat, Elvira Sondo, Catherine Costa, Nicole Arous, Christine Gameiro, Natacha Martin, Agathe Tarze, Laurence Weiss, Alix de Becdelièvre, Bruno Costes, Michel Goossens, Luis J. Galietta, Emmanuelle Girodon, Pascale Fanen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Approximately 30% of alleles causing genetic disorders generate premature termination codons (PTCs), which are usually associated with severe phenotypes. However, bypassing the deleterious stop codon can lead to a mild disease outcome. Splicing at NAGNAG tandem splice sites has been reported to result in insertion or deletion (indel) of three nucleotides. We identified such a mechanism as the origin of the mild to asymptomatic phenotype observed in cystic fibrosis patients homozygous for the E831X mutation (2623G>T) in the CFTR gene. Analyses performed on nasal epithelial cell mRNA detected three distinct isoforms, a considerably more complex situation than expected for a single nucleotide substitution. Structure-function studies and in silico analyses provided the first experimental evidence of an indel of a stop codon by alternative splicing at a NAGNAG acceptor site. In addition to contributing to proteome plasticity, alternative splicing at a NAGNAG tandem site can thus remove a disease-causing UAG stop codon. This molecular study reveals a naturally occurring mechanism where the effect of either modifier genes or epigenetic factors could be suspected. This finding is of importance for genetic counseling as well as for deciding appropriate therapeutic strategies.

Original languageEnglish
Article numbere1001153
Pages (from-to)1-11
Number of pages11
JournalPLoS Genetics
Volume6
Issue number10
DOIs
Publication statusPublished - Oct 2010

Fingerprint

modifiers (genes)
Terminator Codon
stop codon
alternative splicing
Alternative Splicing
phenotype
Phenotype
gene
Nucleotides
Modifier Genes
plasticity
mutation
allele
Inborn Genetic Diseases
substitution
Nonsense Codon
nucleotides
Genetic Counseling
Proteome
Nose

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Cancer Research
  • Genetics(clinical)

Cite this

Hinzpeter, A., Aissat, A., Sondo, E., Costa, C., Arous, N., Gameiro, C., ... Fanen, P. (2010). Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier. PLoS Genetics, 6(10), 1-11. [e1001153]. https://doi.org/10.1371/journal.pgen.1001153

Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier. / Hinzpeter, Alexandre; Aissat, Abdel; Sondo, Elvira; Costa, Catherine; Arous, Nicole; Gameiro, Christine; Martin, Natacha; Tarze, Agathe; Weiss, Laurence; de Becdelièvre, Alix; Costes, Bruno; Goossens, Michel; Galietta, Luis J.; Girodon, Emmanuelle; Fanen, Pascale.

In: PLoS Genetics, Vol. 6, No. 10, e1001153, 10.2010, p. 1-11.

Research output: Contribution to journalArticle

Hinzpeter, A, Aissat, A, Sondo, E, Costa, C, Arous, N, Gameiro, C, Martin, N, Tarze, A, Weiss, L, de Becdelièvre, A, Costes, B, Goossens, M, Galietta, LJ, Girodon, E & Fanen, P 2010, 'Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier', PLoS Genetics, vol. 6, no. 10, e1001153, pp. 1-11. https://doi.org/10.1371/journal.pgen.1001153
Hinzpeter, Alexandre ; Aissat, Abdel ; Sondo, Elvira ; Costa, Catherine ; Arous, Nicole ; Gameiro, Christine ; Martin, Natacha ; Tarze, Agathe ; Weiss, Laurence ; de Becdelièvre, Alix ; Costes, Bruno ; Goossens, Michel ; Galietta, Luis J. ; Girodon, Emmanuelle ; Fanen, Pascale. / Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier. In: PLoS Genetics. 2010 ; Vol. 6, No. 10. pp. 1-11.
@article{9253ca384053438c81a3e6191aa14bed,
title = "Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier",
abstract = "Approximately 30{\%} of alleles causing genetic disorders generate premature termination codons (PTCs), which are usually associated with severe phenotypes. However, bypassing the deleterious stop codon can lead to a mild disease outcome. Splicing at NAGNAG tandem splice sites has been reported to result in insertion or deletion (indel) of three nucleotides. We identified such a mechanism as the origin of the mild to asymptomatic phenotype observed in cystic fibrosis patients homozygous for the E831X mutation (2623G>T) in the CFTR gene. Analyses performed on nasal epithelial cell mRNA detected three distinct isoforms, a considerably more complex situation than expected for a single nucleotide substitution. Structure-function studies and in silico analyses provided the first experimental evidence of an indel of a stop codon by alternative splicing at a NAGNAG acceptor site. In addition to contributing to proteome plasticity, alternative splicing at a NAGNAG tandem site can thus remove a disease-causing UAG stop codon. This molecular study reveals a naturally occurring mechanism where the effect of either modifier genes or epigenetic factors could be suspected. This finding is of importance for genetic counseling as well as for deciding appropriate therapeutic strategies.",
author = "Alexandre Hinzpeter and Abdel Aissat and Elvira Sondo and Catherine Costa and Nicole Arous and Christine Gameiro and Natacha Martin and Agathe Tarze and Laurence Weiss and {de Becdeli{\`e}vre}, Alix and Bruno Costes and Michel Goossens and Galietta, {Luis J.} and Emmanuelle Girodon and Pascale Fanen",
year = "2010",
month = "10",
doi = "10.1371/journal.pgen.1001153",
language = "English",
volume = "6",
pages = "1--11",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier

AU - Hinzpeter, Alexandre

AU - Aissat, Abdel

AU - Sondo, Elvira

AU - Costa, Catherine

AU - Arous, Nicole

AU - Gameiro, Christine

AU - Martin, Natacha

AU - Tarze, Agathe

AU - Weiss, Laurence

AU - de Becdelièvre, Alix

AU - Costes, Bruno

AU - Goossens, Michel

AU - Galietta, Luis J.

AU - Girodon, Emmanuelle

AU - Fanen, Pascale

PY - 2010/10

Y1 - 2010/10

N2 - Approximately 30% of alleles causing genetic disorders generate premature termination codons (PTCs), which are usually associated with severe phenotypes. However, bypassing the deleterious stop codon can lead to a mild disease outcome. Splicing at NAGNAG tandem splice sites has been reported to result in insertion or deletion (indel) of three nucleotides. We identified such a mechanism as the origin of the mild to asymptomatic phenotype observed in cystic fibrosis patients homozygous for the E831X mutation (2623G>T) in the CFTR gene. Analyses performed on nasal epithelial cell mRNA detected three distinct isoforms, a considerably more complex situation than expected for a single nucleotide substitution. Structure-function studies and in silico analyses provided the first experimental evidence of an indel of a stop codon by alternative splicing at a NAGNAG acceptor site. In addition to contributing to proteome plasticity, alternative splicing at a NAGNAG tandem site can thus remove a disease-causing UAG stop codon. This molecular study reveals a naturally occurring mechanism where the effect of either modifier genes or epigenetic factors could be suspected. This finding is of importance for genetic counseling as well as for deciding appropriate therapeutic strategies.

AB - Approximately 30% of alleles causing genetic disorders generate premature termination codons (PTCs), which are usually associated with severe phenotypes. However, bypassing the deleterious stop codon can lead to a mild disease outcome. Splicing at NAGNAG tandem splice sites has been reported to result in insertion or deletion (indel) of three nucleotides. We identified such a mechanism as the origin of the mild to asymptomatic phenotype observed in cystic fibrosis patients homozygous for the E831X mutation (2623G>T) in the CFTR gene. Analyses performed on nasal epithelial cell mRNA detected three distinct isoforms, a considerably more complex situation than expected for a single nucleotide substitution. Structure-function studies and in silico analyses provided the first experimental evidence of an indel of a stop codon by alternative splicing at a NAGNAG acceptor site. In addition to contributing to proteome plasticity, alternative splicing at a NAGNAG tandem site can thus remove a disease-causing UAG stop codon. This molecular study reveals a naturally occurring mechanism where the effect of either modifier genes or epigenetic factors could be suspected. This finding is of importance for genetic counseling as well as for deciding appropriate therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=78449232308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449232308&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1001153

DO - 10.1371/journal.pgen.1001153

M3 - Article

VL - 6

SP - 1

EP - 11

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 10

M1 - e1001153

ER -